<DOC>
	<DOCNO>NCT01716663</DOCNO>
	<brief_summary>This prospective , multicenter , non-randomized observational study subject 18 year old undergo RF ablation drug refractory recurrent symptomatic paroxysmal Atrial Fibrillation ( AF ) .</brief_summary>
	<brief_title>CARTO® 3 System Real Time Intracardiac Ultrasound</brief_title>
	<detailed_description>This study purpose measure `` real world '' acute procedural outcome ( procedural efficiency acute safety ) associate use CARTO® 3 System real time intracardiac ultrasound clinical setting subject drug refractory recurrent symptomatic paroxysmal AF .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Drug refractory , recurrent symptomatic paroxysmal AF Age 18 year old Patients able willing provide write informed consent participate study comply study requirement Atrial fibrillation secondary electrolyte imbalance , thyroid disease , reversible noncardiac cause Previous ablation atrial fibrillation AF episodes last longer 30 day Uncontrolled heart failure , NYHA Class III IV heart failure Documented intraatrial thrombus abnormality preablation image Contraindication anticoagulation Stroke , cardiac surgery , unstable angina , myocardial infarction percutaneous coronary intervention within past 3 month Awaiting cardiac transplantation Heart disease corrective surgery anticipate within 6 month Enrollment investigational drug device study Subjects unwilling comply protocol followup requirement Patients pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Symptomatic paroxysmal</keyword>
	<keyword>Atrial fibrillation</keyword>
	<keyword>Observational</keyword>
	<keyword>Acute procedural outcome</keyword>
	<keyword>Ablation</keyword>
</DOC>